Inamed was founded in 1998 as a spin-off of the GSF National Research Center for Environment and Health (now called Helmholtz Research Centre). Therefore INAMED profits from more than 30 years of experience in aerosol biophysics and technology. Our initial vision was to make optimized inhalation therapies a reality.
Since that time, we grew our expertise in clinical trials through-out all phases, and wide variety of indications, far beyond “respiratory”.
Inamed provides its clients a broad range of clinical trial services, ranging from Phase-I trials (First-in-Man trials, safety, pharmacokinetic and pharmacodynamic trials in healthy subjects or patients), Phase II-IV trials (clinical efficacy trials in patients), clinical investigations with medical devices (e.g., inhalers), and related clinical trial services such as project management, medical writing, data management, biostatistical evaluation, quality assurance, regulatory affairs and consulting.
As internationally acting contract research organization Inamed provides its clients with the full range of services, required for the planning, conduct and evaluation of clinical trials throughout all phases and geographical regions.